• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC VIRAL PANEL; GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC VIRAL PANEL; GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM Back to Search Results
Catalog Number 443985
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/31/2024
Event Type  malfunction  
Manufacturer Narrative
H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that during use of the kit bd max ext enteric bacterial panel, false positive results on sapovirus and norovirus were obtained.False results were not reported to physician because customer always check positive results/curves.There has been no harm to patients.
 
Manufacturer Narrative
The following information has been updated with corrected and/or additional information: b.5.Describe event or problem: it was reported that during use of the bd max¿ enteric viral panel, false positive results on sapovirus and adenovirus were obtained.False results were not reported to physician because customer always check positive results/curves.There has been no harm to patients.D.1.Medical device brand name: bd max¿ enteric viral panel d.2.Medical device catalog #: 443985 d.4.Medical device lot #: unknown d.4.Unique identifier (udi) #: (b)(4).G.5.Pma/510(k)#: k220607 h.6.Investigation summary: the complaint investigation for suspected false positive sapovirus (sav) and adenovirus (adv) results when using the bd max¿ enteric viral panel assay (ref.(b)(4) unknown lot number was performed by the analysis of the customer¿s data and verification of complaints history.Customer provided the database of instrument ct1108.Database analysis showed that the rate of positive results varied in time and not linked to specific lots.Despite multiple attempts made to receive information from the customer, no kit lot number nor samples identification about the runs in which the suspected false positive results occurred was provided for the investigation.Only a description in the complaint text was available and database of instrument ct1108 was searched to identify the samples corresponding to the information received (discrepant results of repeated adenovirus with norovirus positive results in initial test and samples discrepant results for the sapovirus target which also tested positive for another target).No samples corresponding to these descriptions could be identified in the database and bd was thus unable to investigate the issue reported by the customer.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max enteric viral panel assays.The root cause was not identified.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action (capa) since no new hazard was identified.Bd quality will continue to monitor for trends.H3 other text : see h.10.
 
Event Description
It was reported that during use of the bd max¿ enteric viral panel, false positive results on sapovirus and adenovirus were obtained.False results were not reported to physician because customer always check positive results/curves.There has been no harm to patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ ENTERIC VIRAL PANEL
Type of Device
GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18771023
MDR Text Key336137501
Report Number3007420875-2024-00009
Device Sequence Number1
Product Code PCH
UDI-Device Identifier00382904439859
UDI-Public(01)00382904439859
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
K220607
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number443985
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/31/2024
Initial Date FDA Received02/23/2024
Supplement Dates Manufacturer Received04/03/2024
Supplement Dates FDA Received04/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-